EXOSC3 antibody (Middle Region)
Quick Overview for EXOSC3 antibody (Middle Region) (ABIN2778687)
Target
See all EXOSC3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Middle Region
-
Sequence
- TKCGRLRHKE PGSGSGGGVY WVDSQQKRYV PVKGDHVIGI VTAKSGDIFK
-
Predicted Reactivity
- Cow: 100%, Dog: 100%, Guinea Pig: 100%, Horse: 100%, Human: 100%, Mouse: 100%, Rabbit: 100%, Rat: 100%
-
Characteristics
- This is a rabbit polyclonal antibody against EXOSC3. It was validated on Western Blot and immunohistochemistry.
-
Purification
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the middle region of human EXOSC3
-
-
-
-
Application Notes
- Optimal working dilutions should be determined experimentally by the investigator.
-
Comment
-
Antigen size: 275 AA
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- EXOSC3 (Exosome Component 3 (EXOSC3))
-
Alternative Name
- EXOSC3
-
Background
-
EXOSC3 is component of the exosome 3'->5' exoribonuclease complex and is required for the 3' processing of the 7S pre-RNA to the mature 5.8S rRNA.
Alias Symbols: p10, RRP40, Rrp40p, CGI-102, hRrp-40, hRrp40p, bA3J10.7, RP11-3J10.8
Protein Interaction Partner: UBC, EXOSC5, EXOSC4, CDK5RAP1, EXOSC8, ATP5D, AICDA, EXOSC10, EXOSC9, APP, EXOSC2, EXOSC6, DIS3L, EXOSC1, EXOSC3, EXOSC7, DIS3, MPHOSPH6, HDGF, KHSRP,
Protein Size: 275 -
Molecular Weight
- 30 kDa
-
Gene ID
- 51010
-
NCBI Accession
- NM_016042, NP_057126
-
UniProt
- Q9NQT5
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, SARS-CoV-2 Protein Interactome
Target
-